Urodynamic outcomes after pelvic nerve-sparing radical hysterectomy with or without neoadjuvant chemotherapy.
Tsunetoh S, Terai Y, Takai M, Fujiwara S, Tanaka Y, Tanaka T, Sasaki H, Ibuki N, Ubai T, Yamamoto K, Azuma H, Ohmichi M.
Tsunetoh S, et al. Among authors: tanaka t, tanaka y.
Oncotarget. 2019 Aug 27;10(50):5207-5216. doi: 10.18632/oncotarget.27147. eCollection 2019 Aug 27.
Oncotarget. 2019.
PMID: 31497250
Free PMC article.